One-pot, degradable, silica nanocarriers with encapsulated oligonucleotides for mitochondrial specific targeting
{{output}}
Mutations in nuclear and mitochondrial genes are responsible for severe chronic disorders such as mitochondrial myopathies. Gene therapy using antisense oligonucleotides is a promising strategy to treat mitochondrial DNA (mtDNA) diseases by blocking the replic... ...